区域淀粉样蛋白沉积的体内分期
该研究基于ADNI队列667名参与者的florbetapir PET数据,构建了四阶段淀粉样蛋白沉积区域进展模型,发现沉积从颞基底和额内侧区开始,依次累及联合新皮层、初级感觉运动区和内侧颞叶,最终累及纹状体,且该分级在个体间高度一致。
要点
- 淀粉样蛋白PET沉积呈四阶段区域进展模式,仅2%个体偏离该分级。
- 常规全局二分类法常遗漏最早期的体内淀粉样蛋白阶段。
- 早期阶段与脑脊液Aβ42水平显著降低相关,晚期阶段与认知损害相关。
核心结论
- 基于florbetapir PET的区域淀粉样蛋白沉积呈现高度一致的分级顺序,可用于个体淀粉样病理的体内分期。
研究设计与样本
- 对阿尔茨海默病神经影像学倡议(ADNI)队列中667名参与者的florbetapir(18F-AV45)PET数据进行多区域分析,包括认知正常老年人、轻度认知障碍和阿尔茨海默病痴呆患者。
主要发现
- 淀粉样沉积始于颞基底和额内侧区,依次累及剩余联合新皮层、初级感觉运动区和内侧颞叶,最终累及纹状体。
- 仅2%的参与者分布模式偏离该分级方案。
- 早期体内淀粉样阶段常被基于全局florbetapir PET信号的常规二分类法遗漏,但与脑脊液Aβ42水平显著降低相关。
- 晚期体内淀粉样阶段在AD患者中最常见,且与无痴呆个体的认知损害相关。
临床怎么用
- 可利用区域淀粉样蛋白PET沉积的四阶段模型对个体淀粉样病理进行体内分期,弥补全局二分类法的不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To estimate a regional progression pattern of amyloid deposition from cross-sectional amyloid-sensitive PET data and evaluate its potential for in vivo staging of an individual's amyloid pathology. METHODS: Multiregional analysis of florbetapir (18F-AV45)-PET data was used to determine individual amyloid distribution profiles in a sample of 667 participants from the Alzheimer's Disease Neuroimaging Initiative cohort, including cognitively normal older individuals (CN) as well as patients with mild cognitive impairment and Alzheimer disease (AD) dementia. The frequency of regional amyloid positivity across CN individuals was used to construct a 4-stage model of progressing amyloid pathology, and individual distribution profiles were used to evaluate the consistency of this hierarchical stage model across the full cohort. RESULTS: According to a 4-stage model, amyloid deposition begins in temporobasal and frontomedial areas, and successively affects the remaining associative neocortex, primary sensory-motor areas and the medial temporal lobe, and finally the striatum. Amyloid deposition in these brain regions showed a highly consistent hierarchical nesting across participants, where only 2% exhibited distribution profiles that deviated from the staging scheme. The earliest in vivo amyloid stages were mostly missed by conventional dichotomous classification approaches based on global florbetapir-PET signal, but were associated with significantly reduced CSF Aβ42 levels. Advanced in vivo amyloid stages were most frequent in patients with AD and correlated with cognitive impairment in individuals without dementia. CONCLUSIONS: The highly consistent regional hierarchy of PET-evidenced amyloid deposition across participants resembles neuropathologic observations and suggests a predictable regional sequence that may be used to stage an individual's progress of amyloid pathology in vivo.
引用
- Grothe MJ, Barthel H, Sepulcre J, et al. In vivo staging of regional amyloid deposition. Neurology. 2017. PMID: 29046362. doi:10.1212/WNL.0000000000004643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。